simon bowman

simon bowman i

University of Birmingham - Birmingham / United Kingdom
Others
AD Scientific Index ID: 4321633
person_outline simon bowman's MOST POPULAR ARTICLES
1-) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Lancet (London, England) 397 (10285), 1637, 2021
2-) EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome Annals of the rheumatic diseases 69 (6), 1103-1109, 2010
3-) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial The Lancet 399 (10325), 665-676, 2022
4-) Sjögren syndrome Nature reviews Disease primers 2 (1), 1-20, 2016
5-) RECOVERY Collaborative Group Dexamethasone in hospitalized patients with Covid-19P Horby, WS Lim, JR Emberson, M Mafham, JL Bell, L Linsell, N Staplin, ...N Engl J Med 384 (8), 693-704, 2021635*2021